Menu

CanRIO Member Publications

Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist

Posted July 10, 2019

J Rheum 2019
Immune checkpoint inhibitors have revolutionized cancer therapy by blocking inhibitory pathways of the immune system to fight cancer cells. Their use… Read More

Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor-induced inflammatory arthritis

Posted May 1, 2019

Clin Rheumatol 2019
Immunotherapy for cancer treatment continues to evolve, and immune checkpoints have proven successful therapeutic targets. With success has come the challenge… Read More

Immune Checkpoint Inhibitor Associated Rheumatic Adverse Events: a Review of Their Presentations and Treatments

Posted January 19, 2019

Curr Treat Options in Rheum 2019
Purpose of review: Immune checkpoint inhibitors (ICI) are now the cornerstone of treatment for metastatic melanoma and are… Read More

Hepatitis is the new myositis: immune checkpoint inhibitor-induced myositis

Posted October 28, 2018

Melanoma Res 2018
This article describes two cases of myositis associated with immune checkpoint inhibitor therapy for melanoma, in which both diagnoses were delayed… Read More

Adverse events associated with immune checkpoint inhibitor treatment for cancer

Posted March 22, 2018

CMAJ 2019
Inhibitors against cytotoxic T-lymphocyte--associated protein 4 and programmed cell death 1 immune checkpoints are novel agents that modulate immune pathways and enhance… Read More

Rheumatic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitors for Cancer: Coming soon to a clinic near you.

Posted January 18, 2018

CRAJ 2018
An overview of rheumatologic immune-related adverse events associated with immune checkpoint inhibitors, along with a case description of inflammatory polyarthritis developing after… Read More